New varieties of medical marijuana in pharmacies. Less THC, more CBD.

Spectrum Cannabis recently announced that it will apply for registration of a new variety of medical marijuana in the next few days. The new 'variety' of medical marijuana is expected to have a lower concentration than Red No.2.

So far, the Canadian company is the only one to have received approval to bring medical marijuana to Poland. Available in dispensaries, Red No.2 is Lemon Skunk with a concentration of 19% THC and less than 1% CBD. The relatively high THC content does not suit all patients, mainly children with neurological diseases, Dr.Marek Bachanski said in a recent interview with Polityka.

Medicine or stimulant?

In early March, Spectrum Cannabis announced it would bring another 15kg of Red No.2 to Poland. The first batch (7kg) sold out in just a few days. There is a widespread opinion in some circles that the availability of medical marijuana with such a high concentration of THC has "brought soft drugs into pharmacies through the back door."

This was brilliantly addressed by Jedrzej Sadowski of the Free Hemp Association: "First of all, it is completely legal to buy various substances dangerous to health in a pharmacy, both with and without a prescription (and not only in a pharmacy). Far more dangerous than medical marijuana."

The problem here is legislation and procedures hindering the introduction of a wider range of products for sale, which you can read about on the Free Hemp website.

Poles want CBD

The dried CBD available in pharmacies has a very broad spectrum of uses, as evidenced by the sales results of Red No.2 in Germany. High concentrations of psychoactive THC are essential for many conditions, especially considering the fact of building tolerance in patients.

However, Spectrum Cannabis representatives are open to suggestions from Poles, and an application for registration of a product with a THC to CBD ratio of 1:1 is expected to be submitted within a few weeks. Specifically, the dry is expected to have 10% THC and 9% CBD. By the end of 2019, 2 new products are expected to appear in our pharmacies